Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
KAEF.JK
HoldSinkerPT Kimia Farma Tbk · Healthcare · Indonesia · $150M · Avg Vol: $93K/d
35
StockRankGet insider-trade alerts
Q
40
V
41
M
46
P/E (TTM)
—
ROE
-8.3%
D/E
2.7x
Dividend %
—
COMPANY DESCRIPTION
PT Kimia Farma Tbk, together with its subsidiaries, manufactures and sells a range of medicines in Indonesia and internationally. It operates through Manufacture, Distribution, Retail, and Others segments.
FINANCIAL SUMMARY (IDR)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM |
|---|---|---|---|---|---|---|
| Revenue | 9.2T | 9.9T | 9.9T | 9.2T | -0.0% | 9.6T |
| EPS (IDR) | -34.25 | -353.14 | -151.31 | -60.17 | — | -41.24 |
| Shares | 5.6B | 5.6B | 5.6B | 5.6B | +0.2% | 5.6B |
| Debt | 8.1T | 7.7T | 7.3T | 7.0T | -4.9% | 7.4T |
| Equity | 5.8T | 3.2T | 2.3T | 1.8T | -32.7% | — |
| Op CF | 403.3B | -246.1B | 153.6B | 234.4B | -16.6% | 216.1B |
| Inv CF | -429.4B | -849.9B | -101.2B | -136.0B | — | — |
| Fin CF | 1.5T | -272.0B | -399.1B | -159.6B | — | — |
Loading 1Y...
PRICE (1Y)+5.4%
SMA 50SMA 200
Close
$0.0266
RSI (14)
58.8
52W High
$0.0448
From 52W High
0.6%
SCORE BREAKDOWN
Quality
40
ROIC
-1.5%42.8
ROE
-8.3%36.5
GP/Assets
21.1%46.6
Op. Margin
3.2%48.2
FCF/Assets
-1.0%42.7
Piotroski
668.8
Int. Cover
0.3x36.5
D/E Ratio
2.66x3.8
Current Ratio
1.03x11.8
Value
41
P/E (TTM)
—N/A
EV/EBITDA
29.4x22.1
P/FCF
—N/A
P/B
0.9x88.6
P/S
0.3x97.0
Div Yield
—N/A
Momentum
46
52W High %
59%33.6
RS 6M
13%76.2
SMA 50/200
0.91x33.2
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
—N/A
Q Growth
—N/A
FUNDAMENTALS
Market Cap
$150M
P/E (Forward)
—
Gross Margin
31.3%
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of KAEF.JK are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| KAEF.JK | PT Kimia Farma Tbk(you) | $150M | 35 | Hold |
| SOHO.JK | PT Soho Global Health Tbk | $1.2B | 57 | Hold |
| LPKR.JK | PT Lippo Karawaci Tbk | $249M | 40 | Hold |
| SAME.JK | PT Sarana Meditama Metropolitan Tbk | $308M | 46 | Hold |
| HEAL.JK | PT Medikaloka Hermina Tbk | $589M | 35 | Sell |
| PYFA.JK | PT Pyridam Farma Tbk | $168M | 9 | Strong Sell |
| PRDA.JK | PT Prodia Widyahusada Tbk | $142M | 100 | Strong Buy |
| MARK.JK | PT Mark Dynamics Indonesia Tbk | $233M | 100 | Strong Buy |
| SILO.JK | PT Siloam International Hospitals Tbk | $1.6B | 78 | Buy |
| MIKA.JK | PT Mitra Keluarga Karyasehat Tbk | $1.5B | 84 | Strong Buy |
Peer medians: ROE 9.2% · P/E 18.6x · Gross margin 37.3%